Nurofen class action could yield very small individual payments, lawyer says

Painkiller manufacturer Reckitt Benckiser settled an Australian class action over its specific pain range last month

A $3.5m class action over Nurofen tablets that falsely claimed they could target specific types of pain could yield very small payments for individual claimants, if everyone who bought the products steps forward.

The painkiller’s manufacturer, Reckitt Benckiser, settled the class action over its specific pain range at the federal court in Sydney last month.

Related: Nurofen maker’s fine for misleading consumers increased from $1.7m to $6m

Related: Nurofen manufacturer fined $1.7m for misleading customers

Continue reading…

Pharmaceutical Stocks


© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us